Navigation Links
PDL BioPharma Announces Fourth Quarter and Full Year 2012 Financial Results
Date:3/1/2013

ome generating assets and maximizing value for its shareholders. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

Forward-looking StatementsThis press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from those, express or implied, in these forward-looking statements. Important factors that could impair the value of the Company's royalty assets, restrict or impede the ability of the Company to invest in new income generating assets and limit the Company's ability to pay dividends are disclosed in the risk factors contained in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission. All forward-looking statements are expressly qualified in their entirety by such factors. We do not undertake any duty to update any forward-looking statement except as required by law.

 PDL BIOPHARMA, INC.CONDENSED CONSOLIDATED STATEMENTS OF INCOME DATA(Unaudited)(In thousands, except per share amounts)Three Months EndedYear EndedDecember 31,December 31,2012201120122011RevenuesRoyalties$86,046$  72,808$374,525$351,641License and other---10,400Total revenues86,04672,808374,525362,041Operating ExpensesGeneral and administrative expenses7,7324,82225,46918,338Operating income78,31467,986349,056343,703Non-operating expense, netLoss on retirement or conversion of convertible notes---(766)Interest and other income, net4,7281307,113593Interest expense(5,950)(8,161)(29,036)(36,102)Total non-operating expense, net(1,222)(8,031)(21,923)(36,275)Income before income taxes77,09259,955327,133307,428Income tax expense27,68421,013115,464108,039Net inco
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
2. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
3. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
4. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
5. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
6. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
7. S1 Biopharma Expands Focus to Include Male Sexual Health
8. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
9. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
10. Cell Therapeutics Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
11. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... /CNW Telbec/ - Russell Williams , President of ... welcomes the 2015-2016 Quebec Budget, noting the fiscal discipline ... biopharmaceutical industry. However, the association is concerned about the ... the government,s intent to strive for a balanced budget ... Quebec,s economic development is encouraging," ...
(Date:3/27/2015)... VICTORIA, Texas , March 27, 2015  Victoria Vein ... removal services with the Astanza Duality laser in ... of vein disease as well as advanced laser treatments for ... are entering the tattoo industry to provide more services for ... Surgery has helped many Victoria residents ...
(Date:3/27/2015)... , March 27, 2015 A new report from ... America – Chile , ... are top targets for IVD firms.  The healthcare research firm ... into IVD strategies for the Latin American continent with a ... globally distributed supply operations. However, the country,s regional economic clout ...
Breaking Medicine Technology:Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3Victoria Vein And Surgery Clinic Uses Advanced Astanza Duality Tattoo Removal Technology 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4
... to confirmed EDSS progression reduced by 40 percent ... – Bayer Schering Pharma AG,Germany, announced today new ... beta-1b) treatment in,patients with a first event suggestive ... of permanent neurological,impairment as measured by the Expanded ...
... efficacy across the range of migraine symptoms, BOSTON, ... experience traditional symptoms such as nausea or,sensitivity to ... like neck pain or sinus pain that are ... that,significantly more patients using the investigational migraine,treatment Trexima ...
Cached Medicine Technology:Immediate Treatment of Early MS Patients with Betaferon,Significantly Delayed Permanent Disability 2Immediate Treatment of Early MS Patients with Betaferon,Significantly Delayed Permanent Disability 3Immediate Treatment of Early MS Patients with Betaferon,Significantly Delayed Permanent Disability 4Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both,Traditional and Non-traditional Migraine Symptoms 2Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both,Traditional and Non-traditional Migraine Symptoms 3Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both,Traditional and Non-traditional Migraine Symptoms 4Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both,Traditional and Non-traditional Migraine Symptoms 5
(Date:3/27/2015)... According to Health Day , on ... Abstinence Syndrome (NAS) are causing alarm for Florida officials. ... process for a month of their lives- and can ... vomiting. The condition is precipitated by drug use during ... (and employing medically assisted drug treatment) will also inflict ...
(Date:3/27/2015)... SMI (Silicon Microstructures, Inc.), a global ... the SM1120 MEMS based ultra-miniature pressure sensor designed especially ... at only 220um x 75um provides ample space for ... With industry leading in vivo drift performance of ... broad operating pressure range from 0 to 1,100 mmHg ...
(Date:3/27/2015)... OR (PRWEB) March 27, 2015 California’s ... winter blizzards in Boston and the United States Northeast, ... patterns. Earth warming global atmosphere is creating changes in ... PhD, historical climatologist and former NASA researcher, speaking on ... The result is not only a warmer and dryer ...
(Date:3/27/2015)... 2015 Operatic contenders and their avid ... April 17th. The universally acclaimed baritone Sherrill Milnes will ... Opera Idol at The Merion in Evanston. The event ... drawn aspiring opera singers from around the country. “This ... the finest young talent in the country,” said Margaret ...
(Date:3/27/2015)... To address their number one lawn care question ... filming this video to explain the complicated dynamics between the ... often expected to thrive in, be it in dense building ... survive. Anytime a sun-loving plant is put in the shade ... homeowners try to amend this issue by applying large quantities ...
Breaking Medicine News(10 mins):Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:SMI Launches Catheter Mountable Pressure Sensor 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 3Health News:Opera Idol Competition At The Merion In Evanston 2Health News:For Spring Turf Planting Season, Super-Sod Created a New How-To Video Entitled "Two Views on Shade and Turf" 2
... treatment could prevent several bone problems, , TUESDAY, Oct. 27 ... treatment with large doses of vitamin D2 can eliminate vitamin ... bay for up to six years. , The dosage ... was large but did not appear to be toxic, according ...
... ... vast reach across the U.S. healthcare industry with Susan G. Komen,s mission to cure ... ... with Susan G. Komen for the Cure®, the world,s largest breast cancer advocacy organization. ...
... Robert A. Douglas, 1st Vice President Senior Consultant Sales, ... Career Division national sales growth, Expansion of new RJR sales ... management experience and over 6 years of sales training experience ... in the development and implementation of several new divisions to ...
... Vestara, ... has been awarded a MedAssets supplier contract. MedAssets serves more than 1,700 hospitals and ... ... provider of the industry,s only automated pharmaceutical waste management solution, announced today that it ...
... , ... Homonculus Press, Mexico City, announces the publication of The American ... revealed two sets of parties of interest: A complaint against the first ... 24 Feb 2006 at the Lumpini Police Station against Bumrungrad International Hospital ...
... ... ... -- Morehead, the human capital research firm, will host a webinar titled "A Two-Pronged Strategy ... 17, 2009 at 1:00 p.m. EST. , , ,In this webinar, David Rowlee, Ph.D., ...
Cached Medicine News:Health News:Short-Term, High-Dose Vitamin D2 May Ease Deficiency 2Health News:Susan G. Komen for the Cure Partners with Healthcare IT Leader Emdeon for Innovative Breast Health Awareness Campaigns 2Health News:Susan G. Komen for the Cure Partners with Healthcare IT Leader Emdeon for Innovative Breast Health Awareness Campaigns 3Health News:Susan G. Komen for the Cure Partners with Healthcare IT Leader Emdeon for Innovative Breast Health Awareness Campaigns 4Health News:Senior Healthcare Consultants and RJR Insurance Services, Inc. Announce 4th Quarter 2009 and 1st Quarter 2010 Sales Management Promotions 2Health News:Senior Healthcare Consultants and RJR Insurance Services, Inc. Announce 4th Quarter 2009 and 1st Quarter 2010 Sales Management Promotions 3Health News:Senior Healthcare Consultants and RJR Insurance Services, Inc. Announce 4th Quarter 2009 and 1st Quarter 2010 Sales Management Promotions 4Health News:Vestara Awarded MedAssets Supplier Contract For Automated Pharmaceutical Waste Management Solution 2Health News:The American Medical Money Machine, the Destruction of Healthcare in America and the Rise of Medical Tourism, a New Book by James R. Goldberg 2Health News:The American Medical Money Machine, the Destruction of Healthcare in America and the Rise of Medical Tourism, a New Book by James R. Goldberg 3Health News:The American Medical Money Machine, the Destruction of Healthcare in America and the Rise of Medical Tourism, a New Book by James R. Goldberg 4Health News:The American Medical Money Machine, the Destruction of Healthcare in America and the Rise of Medical Tourism, a New Book by James R. Goldberg 5Health News:Morehead Presents Webinar on 'A Two-Pronged Strategy to Reduce Nurse Turnover' 2
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
... Tendril SDX is one ... pacing leads. Implantable with a ... reduced body diameter is designed ... venous obstruction and allow introduction ...
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase....
Medicine Products: